The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...

Nonsustained ventricular tachycardia, a type of arrhythmia, can cause short episodes of rapid heart rate and related symptoms. It usually doesn’t affect life expectancy, but treatment can help you ...

Shares of Milestone Pharmaceuticals Inc. gained 25.4% in premarket trading on Monday after the company said its experimental treatment for paroxysmal supraventricular tachycardia met the primary ...

Clinical trial evaluating a novel, non-invasive radiation treatment for ventricular tachycardia refractory to medication and catheter ablation The UAB Departments of Radiation Oncology and Cardiology ...

First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT). FDA's TAP Pilot and ...

The Agency has specifically requested clarification about the time of data recorded for adverse events in the phase 3 trials. The Food and Drug Administration (FDA) has issued a Refusal to File (RTF) ...

Please provide your email address to receive an email when new articles are posted on . A fast-acting nasal spray was safe and effective for patients self-treating for repeated episodes of paroxysmal ...

St. Jude Medical Begins Landmark Clinical Study to Evaluate Effectiveness of Ablation Procedures for Treatment of Ventricular Tachycardia FlexAbility ablation catheter will be used to assess benefits ...

For most adults, the heart beats 60 to 100 times per minute. When someone’s heart beats more than 100 times per minute, they have a condition called tachycardia. During certain specific experiences, ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...